Vyvanse (Avera McKennan Hospital)
Welcome to the PulseAid listing for the Vyvanse drug offered from Avera McKennan Hospital. This Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Avera McKennan Hospital |
NON-PROPRIETARY NAME: | lisdexamfetamine dimesylate |
SUBSTANCE NAME: | LISDEXAMFETAMINE DIMESYLATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2015-09-30 |
END MARKETING DATE: | 0000-00-00 |
Vyvanse HUMAN PRESCRIPTION DRUG Details:
Item Description | Vyvanse from Avera McKennan Hospital |
LABELER NAME: | Avera McKennan Hospital |
DEA SCHEDULE: | CII
|
ACTIVE STRENGTH: | 70(mg/1) |
START MARKETING DATE: | 2015-09-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69189-0137_8f51e054-c331-4ec0-9608-d12219e17c85 |
PRODUCT NDC: | 69189-0137 |
APPLICATION NUMBER: | NDA021977 |
Other LISDEXAMFETAMINE DIMESYLATE Pharmaceutical Manufacturers / Labelers: